Angiodynamics Inc (ANGO)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

14 PLAZA DRIVE LATHAM, NY 12110

Designs, develops, manufactures and markets innovative therapeutic and diagnostic medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease.

Data as of 2020-08-09
Market Cap355.462 Million Shares Outstanding37.695 Million Avg 30-day Volume322.548 Thousand
P/E Ratio Dividend Yield EPS-4.35
Price/Sales1.346 Price cash flow ratio54.4 Price free cash flow ratio-4.6
Book Value12.09 Price to Tangible Book6.21 Alpha-0.01
Short Interest Ratio % Short Interest to Float R-squared0.112595
BETA0.636 52-week High/Low19.8 / 7.48 Stddev0.079703
View SEC Filings from ANGO instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 153 32 (2.1%)
Aggregate 13F shares on 03/31/2020: 36.632 Million 10.735 Million
Aggregate 13F shares on 12/31/2019: 37.025 Million 10.747 Million
Percent change: -1.06% -0.11%
Funds creating new positions: 29 7
Funds Adding to an existing position: 59 12
Funds closing out their position: 28 17
Funds reducing their position: 38 9
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ANGO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ANGO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

40 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CLEMMER JAMES C PRESIDENT AND CEO

  • Officer
  • Director
343,319 2020-07-31 7

TROWBRIDGE STEPHEN A EVP AND CFO

  • Officer
59,260 2020-07-26 5

CAMPBELL CHAD THOMAS SVP/GM, VASCULAR ACCESS

  • Officer
23,724 2020-07-26 5

KAPUSTA MATTHEW C CEO, CFO, MANAGING DIRECTOR

  • Officer
  • Director
297,914 2020-07-22 0

HELSEL DAVE SVP GLOBAL OPERATIONS AND R&D

  • Officer
23,348 2020-07-17 4

DONNELLY HOWARD W

  • Director
90,869 2020-07-14 1

JOHNSON WESLEY

  • Director
84,411 2020-07-14 1

GOULD KEVIN J

  • Director
77,504 2020-07-14 1

METENY DENNIS S

  • Director
106,401 2020-07-14 1

AUEN EILEEN O'SHEA

  • Director
36,663 2020-07-14 1

REED JAN STERN

  • Director
36,979 2020-07-14 1

LICITRA KAREN A

  • Director
22,380 2020-07-14 1

VENKATARAMAN SRIRAM

  • Director
  • 10% Owner
0 2020-06-10 0

HOBBS EAMONN P DIRECTOR

34,355 2020-05-15 0

GREINER MICHAEL SVP - CHIEF FINANCIAL OFFICER

  • Officer
51,383 2020-05-07 2

BOUCHER BRENT J. SVP AND GM OF ONCOLOGY

  • Officer
15,416 2020-02-12 3

BURGSTAHLER DAVID F

  • Director
  • 10% Owner
21,700,785 2020-01-13 0

GOLD JEFFREY

  • Director
0 2019-10-29 0

SIMPSON ROBERT ARTHUR SVP/GM, GLOBAL VASCULAR

  • Officer
15,441 2019-07-26 0

LAPORTE STEVE

  • Director
48,484 2018-07-18 0

RICHARD STARK SVP, GM - ONCOLOGY

  • Officer
20,754 2017-11-15 0

AVISTA CAPITAL PARTNERS GP, LLC

AVISTA CAPITAL PARTNERS, L.P.

AVISTA CAPITAL PARTNERS (OFFSHORE), L.P.

NAVILYST MEDICAL CO-INVEST, LLC

  • 10% Owner
No longer subject to file 2017-04-12 0

FROST MARK T SVP, CFO & TREASURER

  • Officer
1,442 2016-12-05 0

GREINER CHARLES R VP - GLOBAL FRANCHISE

  • Officer
20,910 2016-05-06 0

SOTO JOHN SVP AND CCO

  • Officer
22,452 2015-09-10 0

DEVIVO JOSEPH PRESIDENT AND CEO

  • Officer
  • Director
198,451 2015-09-08 0

BOURNE GEORGE W. IV CTO AND COO

  • Officer
23,613 2014-08-06 0

MCGILL STEPHEN SVP, GM - INTERNATIONAL

  • Officer
20,715 2014-01-28 0

BUCCI VINCENT

  • Director
143,312 2013-10-23 0

APPLING WILLIAM M EVP, R&D AND GLOBAL OPERATIONS

  • Officer
0 2013-07-15 0

MAPES HAROLD EXEC. V. P., GLOBAL OPERATIONS

  • Officer
0 2013-03-11 0

GERSUK D JOSEPH EVP - CFO

  • Officer
47,275 2012-09-04 0

ETLINGER RICHARD SCOTT SVP - GLOBAL OPERATIONS

  • Officer
11,957 2012-08-17 0

PANZER ALAN SVP, GM - VASCULAR

  • Officer
27,500 2012-08-17 0

ECHENBERG PAUL S

  • DIRECTOR EMERITUS
154,412 2012-04-23 0

SOLANO SCOTT J. INTERIM CEO

  • Officer
8,945 2011-08-03 0

ORSATTI CHARLES THOMAS

  • Director
0 2011-08-03 0

MCDONALD DAVID CHIEF FINANCIAL OFFICER

  • Officer
47,706 2011-03-10 0

KELTJENS JAN PRESIDENT & CEO

  • Officer
  • Director
109,276 2011-01-19 0

MCCARTHY SHAWN P SVP - GENERAL MANAGER

  • Officer
10,160 2010-08-17 0

WALLACE LYNDA M. SVP - BUSINESS DEVELOPMENT

  • Officer
0 2010-05-17 0

ROSSELL ROBERT M VP - MARKETING

  • Officer
8,945 2009-10-08 0

MORRIS SEAN SVP - GENERAL MANAGER

  • Officer
10,253 2008-10-21 0

FLAHERTY ROBERT E

  • Director
3,700 2008-08-06 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

CLEMMER JAMES C - Director - Officer PRESIDENT AND CEO

2020-07-31 P 40,000 $8.26 a 343,319 343,319.00 direct

CAMPBELL CHAD THOMAS - Officer SVP/GM, VASCULAR ACCESS

2020-07-27 F 259 $8.80 d 23,724 23,724.00 direct

CLEMMER JAMES C - Director - Officer PRESIDENT AND CEO

2020-07-27 F 1,799 $8.80 d 303,319 303,319.00 direct

TROWBRIDGE STEPHEN A - Officer EVP AND CFO

2020-07-27 F 292 $8.80 d 59,260 59,260.00 direct

CLEMMER JAMES C - Director - Officer PRESIDENT AND CEO

2020-07-26 F 1,876 $8.80 d 305,118 303,319.00 direct

TROWBRIDGE STEPHEN A - Officer EVP AND CFO

2020-07-26 F 314 $8.80 d 59,552 59,260.00 direct

CAMPBELL CHAD THOMAS - Officer SVP/GM, VASCULAR ACCESS

2020-07-26 F 283 $8.80 d 23,983 23,724.00 direct

CAMPBELL CHAD THOMAS - Officer SVP/GM, VASCULAR ACCESS

2020-07-18 F 76 $9.21 d 24,266 24,266.00 direct

CLEMMER JAMES C - Director - Officer PRESIDENT AND CEO

2020-07-18 F 1,483 $9.21 d 306,994 306,994.00 direct

HELSEL DAVE - Officer SVP GLOBAL OPERATIONS AND R&D

2020-07-18 F 207 $9.21 d 23,501 23,348.00 direct

TROWBRIDGE STEPHEN A - Officer EVP AND CFO

2020-07-18 F 248 $9.21 d 60,018 59,866.00 direct

CAMPBELL CHAD THOMAS - Officer SVP/GM, VASCULAR ACCESS

2020-07-18 F 224 $9.21 d 24,342 24,266.00 direct

HELSEL DAVE - Officer SVP GLOBAL OPERATIONS AND R&D

2020-07-18 F 155 $9.21 d 23,348 23,348.00 direct

TROWBRIDGE STEPHEN A - Officer EVP AND CFO

2020-07-18 F 152 $9.21 d 59,866 59,866.00 direct

CLEMMER JAMES C - Director - Officer PRESIDENT AND CEO

2020-07-17 F 2,131 $9.46 d 308,477 306,994.00 direct

HELSEL DAVE - Officer SVP GLOBAL OPERATIONS AND R&D

2020-07-17 F 254 $9.46 d 23,708 23,348.00 direct

TROWBRIDGE STEPHEN A - Officer EVP AND CFO

2020-07-17 F 354 $9.46 d 60,266 59,866.00 direct

CAMPBELL CHAD THOMAS - Officer SVP/GM, VASCULAR ACCESS

2020-07-17 F 262 $9.46 d 24,566 24,266.00 direct

AUEN EILEEN O'SHEA - Director

2020-07-14 A 15,323 a 36,663 36,663.00 direct

TROWBRIDGE STEPHEN A - Officer EVP AND CFO

2020-07-14 A 30,242 a 30,242 60,620.00 direct

HELSEL DAVE - Officer SVP GLOBAL OPERATIONS AND R&D

2020-07-14 A 15,081 a 15,081 23,962.00 direct

CLEMMER JAMES C - Director - Officer PRESIDENT AND CEO

2020-07-14 A 108,871 a 108,871 310,608.00 direct

CAMPBELL CHAD THOMAS - Officer SVP/GM, VASCULAR ACCESS

2020-07-14 A 13,453 a 13,453 24,828.00 direct

REED JAN STERN - Director

2020-07-14 A 15,323 a 36,979 36,979.00 direct

DONNELLY HOWARD W - Director

2020-07-14 A 15,323 a 90,869 90,869.00 direct

TROWBRIDGE STEPHEN A - Officer EVP AND CFO

2020-07-14 A 15,121 a 60,620 60,620.00 direct

HELSEL DAVE - Officer SVP GLOBAL OPERATIONS AND R&D

2020-07-14 A 7,540 a 23,962 23,962.00 direct

CLEMMER JAMES C - Director - Officer PRESIDENT AND CEO

2020-07-14 A 54,435 a 310,608 310,608.00 direct

CAMPBELL CHAD THOMAS - Officer SVP/GM, VASCULAR ACCESS

2020-07-14 A 6,726 a 24,828 24,828.00 direct

JOHNSON WESLEY - Director

2020-07-14 A 15,323 a 84,411 84,411.00 direct

GOULD KEVIN J - Director

2020-07-14 A 15,323 a 77,504 77,504.00 direct

TROWBRIDGE STEPHEN A - Officer EVP AND CFO

2020-07-14 A 44,510 a 44,510 60,620.00 direct

HELSEL DAVE - Officer SVP GLOBAL OPERATIONS AND R&D

2020-07-14 A 22,196 a 22,196 23,962.00 direct

CLEMMER JAMES C - Director - Officer PRESIDENT AND CEO

2020-07-14 A 160,237 a 160,237 310,608.00 direct

CAMPBELL CHAD THOMAS - Officer SVP/GM, VASCULAR ACCESS

2020-07-14 A 19,800 a 19,800 24,828.00 direct

METENY DENNIS S - Director

2020-07-14 A 15,323 a 106,401 106,401.00 direct

LICITRA KAREN A - Director

2020-07-14 A 15,323 a 22,380 22,380.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments